Proteasome inhibitors as experimental therapeutics of autoimmune diseases

Yazar: Verbrugge, Sue Ellen, Scheper, Rik J, Lems, Willem F, de Gruijl, Tanja D, Jansen, Gerrit
Yayımlandı Arthritis Res Ther (2015)

The adhesion molecule L1 regulates transendothelial migration and trafficking of dendritic cells

Yazar: Maddaluno, Luigi, Verbrugge, Sue Ellen, Martinoli, Chiara, Matteoli, Gianluca, Chiavelli, Andrea, Zeng, Yiping, Williams, Elizabeth D., Rescigno, Maria, Cavallaro, Ugo
Baskı/Yayın Bilgisi 2009

High susceptibility of c-KIT(+)CD34(+) precursors to prolonged doxorubicin exposure interferes with Langerhans cell differentiation in a human cell line model

Yazar: van de Ven, Rieneke, Verbrugge, Sue Ellen, Reurs, Anneke W., Bontkes, Hetty J., Hooijberg, Erik, Jansen, Gerrit, Scheper, Rik J., Scheffer, George L., de Gruijl, Tanja D.
Baskı/Yayın Bilgisi 2011

ALK-negative anaplastic large cell lymphoma is sensitive to bortezomib through Noxa upregulation and release of Bax from Bcl-2

Yazar: Cillessen, Saskia A.G.M., Hijmering, Nathalie J., Moesbergen, Laura M., Vos, Wim, Verbrugge, Sue Ellen, Jansen, Gerrit, Visser, Otto J., Oudejans, Joost J., Meijer, Chris J.L.M.
Yayımlandı Haematologica (2015)

Proteasome inhibition and mechanism of resistance to a synthetic, library-based hexapeptide

Yazar: Oerlemans, Ruud, Berkers, Celia R., Assaraf, Yehuda G., Scheffer, George L., Peters, Godefridus J., Verbrugge, Sue Ellen, Cloos, Jacqueline, Slootstra, Jerry, Meloen, Rob H., Shoemaker, Robert H., Dijkmans, Ben A. C., Scheper, Rik J., Ovaa, Huib, Jansen, Gerrit
Yayımlandı Invest New Drugs (2018)

Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors

Yazar: Verbrugge Sue Ellen, Al Marjon, Assaraf Yehuda G, Niewerth Denise, van Meerloo Johan, Cloos Jacqueline, van der Veer Michael, Scheffer George L, Peters Godefridus J, Chan Elena T, Anderl Janet L, Kirk Christopher J, Zweegman Sonja, Dijkmans Ben AC, Lems Willem F, Scheper Rik J, de Gruijl Tanja D, Jansen Gerrit
Baskı/Yayın Bilgisi 2013-01-01

Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors

Yazar: Verbrugge, Sue Ellen, Al, Marjon, Assaraf, Yehuda G, Niewerth, Denise, van Meerloo, Johan, Cloos, Jacqueline, van der Veer, Michael, Scheffer, George L, Peters, Godefridus J, Chan, Elena T, Anderl, Janet L, Kirk, Christopher J, Zweegman, Sonja, Dijkmans, Ben AC, Lems, Willem F, Scheper, Rik J, de Gruijl, Tanja D, Jansen, Gerrit
Baskı/Yayın Bilgisi 2013

Multifactorial resistance to aminopeptidase inhibitor prodrug CHR2863 in myeloid leukemia cells: down-regulation of carboxylesterase 1, drug sequestration in lipid droplets and pro...

Yazar: Verbrugge, Sue Ellen, Al, Marjon, Assaraf, Yehuda G., Kammerer, Sarah, Chandrupatla, Durga M.S.H., Honeywell, Richard, Musters, Rene P.J., Giovannetti, Elisa, O'Toole, Tom, Scheffer, George L., Krige, David, de Gruijl, Tanja D., Niessen, Hans W.M., Lems, Willem F., Kramer, Pieternella A., Scheper, Rik J., Cloos, Jacqueline, Ossenkoppele, Gert J., Peters, Godefridus J., Jansen, Gerrit
Yayımlandı Oncotarget (2015)